User talk:Dmndrucic

February 2021
Welcome to Wikipedia. Because we have a policy against usernames which give the impression that the account represents a group, organization or website, I have blocked this account; please take a moment to create a new account with a username that represents only yourself as an individual and which complies with our username policy or request a change of username. You should also read our conflict of interest guideline and be aware that promotional editing is not acceptable regardless of the username you choose. Additionally, if your contributions to Wikipedia form all or part of work for which you are, or expect to be, paid, you must disclose who is paying you to edit. Please also note that you are permitted to use a username that contains the name of a company or organization if it identifies you individually, such as "Sara Smith at XYZ Company", "Mark at WidgetsUSA", or "FoobarFan87". If your username does not represent a group, organization or website, you may appeal this username block by adding the text at the bottom of your talk page. You may simply create a new account, but you may prefer to change your username to one that complies with our username policy, so that your past contributions are associated with your new username. If you would prefer to change your username, you may appeal this username block by adding the text at the bottom of your talk page. Please note that you may only request a name that is not already in use, so please check here for a listing of already taken names. Thank you. Drmies (talk) 19:53, 11 February 2021 (UTC)

Your submission at Articles for creation: Nexus Pharmaceuticals, Inc (March 4)
 Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted because it included copyrighted content, which is not permitted on Wikipedia.

You are welcome to write an article on the subject, but please do not use copyrighted work.


 * Draft:Nexus Pharmaceuticals, Inc may be deleted at any time unless the copied text is removed. Copyrighted work cannot be allowed to remain on Wikipedia.
 * If you need any assistance, you can ask for help at the [//en.wikipedia.org/w/index.php?title=Wikipedia:WikiProject_Articles_for_creation/Help_desk&action=edit&section=new&nosummary=1&preload=Template:AfC_decline/HD_preload&preloadparams%5B%5D=User_talk:Dmndrucic Articles for creation help desk] or on the [//en.wikipedia.org/w/index.php?title=User_talk:Kammill&action=edit&section=new&nosummary=1&preload=Template:AfC_decline/HD_preload&preloadparams%5B%5D=User_talk:Dmndrucic reviewer's talk page] . or use Wikipedia's real-time chat help from experienced editors.

– Kammill  ⟨talk⟩ 06:35, 4 March 2021 (UTC)

AfC notification: Draft:Nexus Pharmaceuticals, Inc has a new comment
 I've left a comment on your Articles for Creation submission, which can be viewed at Draft:Nexus Pharmaceuticals, Inc. Thanks! – Kammill  ⟨talk⟩ 06:39, 4 March 2021 (UTC)

Your submission at Articles for creation: Nexus Pharmaceuticals, Inc (March 5)
 Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted at this time. The reason left by Curb Safe Charmer was:

The comment the reviewer left was:

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit when they have been resolved.


 * If you would like to continue working on the submission, go to Draft:Nexus Pharmaceuticals, Inc and click on the "Edit" tab at the top of the window.
 * If you now believe the draft cannot meet Wikipedia's standards or do not wish to progress it further, you may request deletion. Please go to Draft:Nexus Pharmaceuticals, Inc, click on the "Edit" tab at the top of the window, add "Db-g7" at the top of the draft text and click the blue "publish changes" button to save this edit.
 * If you do not make any further changes to your draft, in 6 months, it will be considered abandoned and may be deleted.
 * If you need any assistance, or have experienced any untoward behavior associated with this submission, you can ask for help at the [//en.wikipedia.org/w/index.php?title=Wikipedia:WikiProject_Articles_for_creation/Help_desk&action=edit&section=new&nosummary=1&preload=Template:AfC_decline/HD_preload&preloadparams%5B%5D=Draft:Nexus_Pharmaceuticals,_Inc Articles for creation help desk], on the [//en.wikipedia.org/w/index.php?title=User_talk:Curb_Safe_Charmer&action=edit&section=new&nosummary=1&preload=Template:AfC_decline/HD_preload&preloadparams%5B%5D=Draft:Nexus_Pharmaceuticals,_Inc reviewer's talk page] or use Wikipedia's real-time chat help from experienced editors.

Curb Safe Charmer (talk) 17:21, 5 March 2021 (UTC)

March 2021
Hello Dmndrucic. The nature of your edits, such as the one you made to Draft:Nexus Pharmaceuticals, Inc, gives the impression you have an undisclosed financial stake in promoting a topic, but you have not complied with Wikipedia's mandatory paid editing disclosure requirements. Paid advocacy is a category of conflict of interest (COI) editing that involves being compensated by a person, group, company or organization to use Wikipedia to promote their interests. Undisclosed paid advocacy is prohibited by our policies on neutral point of view and what Wikipedia is not, and is an especially serious type of COI; the Wikimedia Foundation regards it as a "black hat" practice akin to black-hat search-engine optimization.

Paid advocates are very strongly discouraged from direct article editing, and should instead propose changes on the talk page of the article in question if an article exists. If the article does not exist, paid advocates are extremely strongly discouraged from attempting to write an article at all. At best, any proposed article creation should be submitted through the articles for creation process, rather than directly.

Regardless, if you are receiving or expect to receive compensation for your edits, broadly construed, you are  required by the Wikimedia Terms of Use to disclose your employer, client and affiliation. You can post such a mandatory disclosure to your user page at User:Dmndrucic. The template Paid can be used for this purpose – e.g. in the form:. If I am mistaken – you are not being directly or indirectly compensated for your edits – please state that in response to this message. Otherwise, please provide the required disclosure. In either case, do not edit further until you answer this message. Curb Safe Charmer (talk) 17:22, 5 March 2021 (UTC)

Concern regarding Draft:Nexus Pharmaceuticals, Inc
Hello, Dmndrucic. This is a bot-delivered message letting you know that Draft:Nexus Pharmaceuticals, Inc, a page you created, has not been edited in at least 5 months. Draft space is not an indefinite storage location for content that is not appropriate for article space.

If your submission is not edited soon, it could be nominated for deletion under CSD G13. If you would like to attempt to save it, you will need to improve it. You may request userfication of the content if it meets requirements.

If the deletion has already occured, instructions on how you may be able to retrieve it are available here.

Thank you for your submission to Wikipedia. FireflyBot (talk) 18:03, 5 August 2021 (UTC)

Your submission at Articles for creation: Nexus Pharmaceuticals, Inc (October 10)
 Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted at this time. The reasons left by Tol were:

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit when they have been resolved.


 * If you would like to continue working on the submission, go to Draft:Nexus Pharmaceuticals, Inc and click on the "Edit" tab at the top of the window.
 * If you now believe the draft cannot meet Wikipedia's standards or do not wish to progress it further, you may request deletion. Please go to Draft:Nexus Pharmaceuticals, Inc, click on the "Edit" tab at the top of the window, add "Db-g7" at the top of the draft text and click the blue "publish changes" button to save this edit.
 * If you do not make any further changes to your draft, in 6 months, it will be considered abandoned and may be deleted.
 * If you need any assistance, or have experienced any untoward behavior associated with this submission, you can ask for help at the [//en.wikipedia.org/w/index.php?title=Wikipedia:WikiProject_Articles_for_creation/Help_desk&action=edit&section=new&nosummary=1&preload=Template:AfC_decline/HD_preload&preloadparams%5B%5D=Draft:Nexus_Pharmaceuticals,_Inc Articles for creation help desk], on the [//en.wikipedia.org/w/index.php?title=User_talk:Tol&action=edit&section=new&nosummary=1&preload=Template:AfC_decline/HD_preload&preloadparams%5B%5D=Draft:Nexus_Pharmaceuticals,_Inc reviewer's talk page] or use Wikipedia's real-time chat help from experienced editors.

Tol (talk &#124; contribs) @ 18:30, 10 October 2021 (UTC)

Your draft article, Draft:Nexus Pharmaceuticals, Inc


Hello, Dmndrucic. It has been over six months since you last edited the Articles for Creation submission or Draft page you started, "Nexus Pharmaceuticals".

In accordance with our policy that Wikipedia is not for the indefinite hosting of material deemed unsuitable for the encyclopedia mainspace, the draft has been deleted. If you plan on working on it further and you wish to retrieve it, you can request its undeletion. An administrator will, in most cases, restore the submission so you can continue to work on it.

Thanks for your submission to Wikipedia, and happy editing. Liz Read! Talk! 16:58, 7 September 2022 (UTC)